Product Name

  • Name

    Tetracycline

  • EINECS 200-481-9
  • CAS No. 60-54-8
  • Article Data14
  • CAS DataBase
  • Density 1.644 g/cm3
  • Solubility 1.7mg/mlL (28 °C) in water
  • Melting Point 172-174 °C
  • Formula C22H24N2O8
  • Boiling Point 790.622 °C at 760 mmHg
  • Molecular Weight 444.441
  • Flash Point 431.953 °C
  • Transport Information
  • Appearance Light yellow crystal
  • Safety 22-36-26
  • Risk Codes 22-36/37/38
  • Molecular Structure Molecular Structure of 60-54-8 (Tetracycline)
  • Hazard Symbols HarmfulXn, IrritantXi
  • Synonyms 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-(7CI,8CI);Abramycin;Achromycin;Acromicina;Actisite;Agromicina;Ambramicina;Arcanacycline;Bio-Tetra;Biocycline;Ciclibion;Cyclomycin;Deschlorobiomycin;Florocycline;Gammatet;Ibicyn;Kinciclina;Latycin;Medocycline;Mericycline;Micycline;NSC 108579;Omegamycin;Orlycycline;Panmycin;Resteclin;Retet;Robitet Robicaps;Tetra-Co;Tetra-Proter;Tetracycline;Tetralan;Tetralen;Tetramig;
  • PSA 181.62000
  • LogP 0.48590

Synthetic route

6-deoxy-6-hydroperoxy-5a,11a-dehydrotetracycline
102851-25-2

6-deoxy-6-hydroperoxy-5a,11a-dehydrotetracycline

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
With hydrogen; platinum In 1,4-dioxane under 2280 Torr; for 8h; Catalytic hydrogenation;62%
Chlortetracycline
57-62-5

Chlortetracycline

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
With palladium on activated charcoal; 2-methoxy-ethanol; triethylamine Hydrogenation;
With 1,4-dioxane; methanol; palladium on activated charcoal Hydrogenation;
rolitetracycline

rolitetracycline

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
With water at 19.85℃; Kinetics; Further Variations:; Temperatures;
3,7-bis-benzyloxy-13-dimethylamino-11-hydroperoxy-4a-hydroxy-11-methyl-12a,13-dihydro-4aH,11H,12H-1-oxa-2-aza-cyclopenta[b]naphthacene-4,5,6-trione

3,7-bis-benzyloxy-13-dimethylamino-11-hydroperoxy-4a-hydroxy-11-methyl-12a,13-dihydro-4aH,11H,12H-1-oxa-2-aza-cyclopenta[b]naphthacene-4,5,6-trione

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
With hydrogen; palladium In 1,4-dioxane at 23℃; under 760 Torr; for 2h;16.0 mg
3,7-bis-benzyloxy-13-dimethylamino-4a-hydroxy-11-methyl-5a-phenylsulfanyl-11a,12,12a,13-tetrahydro-4aH,5aH,11H-1-oxa-2-aza-cyclopenta[b]naphthacene-4,5,6-trione

3,7-bis-benzyloxy-13-dimethylamino-4a-hydroxy-11-methyl-5a-phenylsulfanyl-11a,12,12a,13-tetrahydro-4aH,5aH,11H-1-oxa-2-aza-cyclopenta[b]naphthacene-4,5,6-trione

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: m-chloroperoxybenzoic acid / CH2Cl2 / -78 - 0 °C
1.2: air / CHCl3
2.1: 16.0 mg / H2 / Pd / dioxane / 2 h / 23 °C / 760 Torr
View Scheme
(4aR,5aR,6R,11R,11aS,12aS)-3,7-Bis-benzyloxy-13-dimethylamino-4a,6-dihydroxy-11-methyl-5a-phenylsulfanyl-6,11,11a,12,12a,13-hexahydro-4aH,5aH-1-oxa-2-aza-cyclopenta[b]naphthacene-4,5-dione

(4aR,5aR,6R,11R,11aS,12aS)-3,7-Bis-benzyloxy-13-dimethylamino-4a,6-dihydroxy-11-methyl-5a-phenylsulfanyl-6,11,11a,12,12a,13-hexahydro-4aH,5aH-1-oxa-2-aza-cyclopenta[b]naphthacene-4,5-dione

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 77 percent / o-iodoxybenzoic acid / dimethylsulfoxide / 18 h / 35 °C
2.1: m-chloroperoxybenzoic acid / CH2Cl2 / -78 - 0 °C
2.2: air / CHCl3
3.1: 16.0 mg / H2 / Pd / dioxane / 2 h / 23 °C / 760 Torr
View Scheme
(4aR,5aR,6R,11R,11aS,12aS,13S)-3,7-Bis-benzyloxy-13-dimethylamino-4a-hydroxy-11-methyl-5a-phenylsulfanyl-6-triethylsilanyloxy-6,11,11a,12,12a,13-hexahydro-4aH,5aH-1-oxa-2-aza-cyclopenta[b]naphthacene-4,5-dione

(4aR,5aR,6R,11R,11aS,12aS,13S)-3,7-Bis-benzyloxy-13-dimethylamino-4a-hydroxy-11-methyl-5a-phenylsulfanyl-6-triethylsilanyloxy-6,11,11a,12,12a,13-hexahydro-4aH,5aH-1-oxa-2-aza-cyclopenta[b]naphthacene-4,5-dione

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 76 percent / triethylamine trihydrofluoride / tetrahydrofuran / 12 h / 23 °C
2.1: 77 percent / o-iodoxybenzoic acid / dimethylsulfoxide / 18 h / 35 °C
3.1: m-chloroperoxybenzoic acid / CH2Cl2 / -78 - 0 °C
3.2: air / CHCl3
4.1: 16.0 mg / H2 / Pd / dioxane / 2 h / 23 °C / 760 Torr
View Scheme
7-Methoxy-3-methylphthalide
4938-06-1

7-Methoxy-3-methylphthalide

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 16 steps
1.1: 80 percent / LDA / tetrahydrofuran / 0.25 h / -40 °C
2.1: 90 percent / SOCl2; TEA / CH2Cl2 / 0.17 h / -30 °C
3.1: BBr3 / CH2Cl2 / 0.25 h / -78 °C
4.1: H2; TEA / Pd-black / dioxane; H2O / 1 h
5.1: 72 percent / i-Pr2NEt / tetrahydrofuran; methanol / 2 h
6.1: 85 percent / Br2; (Bu3Sn)2O; MS-4A / CH2Cl2 / 0.25 h / -78 °C
7.1: 91 percent / Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
8.1: Zn / acetic acid / 0.03 h
9.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
9.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
10.1: NH2OH*HCl; TEA / methanol / 0.5 h
11.1: CDI / tetrahydrofuran / 0.75 h
12.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
13.1: 80 percent / formic acid / 1 h / 80 °C
14.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
15.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
16.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
anhydrotetracycline
1665-56-1, 7518-17-4

anhydrotetracycline

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
2: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
(4S,4aS,12aS)-4-Dimethylamino-3,11,12a-trihydroxy-10-methoxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacene-2-carboxylic acid amide
286961-75-9

(4S,4aS,12aS)-4-Dimethylamino-3,11,12a-trihydroxy-10-methoxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacene-2-carboxylic acid amide

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
2: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
3: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
(4S,4aS,12aS)-4-Amino-3,11,12a-trihydroxy-10-methoxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacene-2-carboxylic acid amide
286961-84-0

(4S,4aS,12aS)-4-Amino-3,11,12a-trihydroxy-10-methoxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacene-2-carboxylic acid amide

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 80 percent / formic acid / 1 h / 80 °C
2: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
3: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
4: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
((1S,2S,3S,12aR)-2,6-Dihydroxy-3-hydroxymethyl-4,7-dimethoxy-11-methyl-5-oxo-1,2,3,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester
286961-69-1

((1S,2S,3S,12aR)-2,6-Dihydroxy-3-hydroxymethyl-4,7-dimethoxy-11-methyl-5-oxo-1,2,3,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: 85 percent / Br2; (Bu3Sn)2O; MS-4A / CH2Cl2 / 0.25 h / -78 °C
2.1: 91 percent / Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
3.1: Zn / acetic acid / 0.03 h
4.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
4.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
5.1: NH2OH*HCl; TEA / methanol / 0.5 h
6.1: CDI / tetrahydrofuran / 0.75 h
7.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
8.1: 80 percent / formic acid / 1 h / 80 °C
9.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
10.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
11.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
((1S,4aS,12aR)-6-Hydroxy-3-hydroxymethyl-4,7-dimethoxy-11-methyl-2,5-dioxo-1,2,4a,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester
286961-71-5

((1S,4aS,12aR)-6-Hydroxy-3-hydroxymethyl-4,7-dimethoxy-11-methyl-2,5-dioxo-1,2,4a,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
1.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
2.1: NH2OH*HCl; TEA / methanol / 0.5 h
3.1: CDI / tetrahydrofuran / 0.75 h
4.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
5.1: 80 percent / formic acid / 1 h / 80 °C
6.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
7.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
8.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
((1S,4aS,12aS)-3-Formyl-2,4a,6-trihydroxy-7-methoxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester
286961-73-7

((1S,4aS,12aS)-3-Formyl-2,4a,6-trihydroxy-7-methoxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: NH2OH*HCl; TEA / methanol / 0.5 h
2: CDI / tetrahydrofuran / 0.75 h
3: 68 percent / polyposphoric acid / 0.75 h / 100 °C
4: 80 percent / formic acid / 1 h / 80 °C
5: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
6: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
7: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
((1S,2S,3S,12aR)-2,4,6-Trihydroxy-3-hydroxymethyl-7-methoxy-11-methyl-5-oxo-1,2,3,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester
286961-82-8

((1S,2S,3S,12aR)-2,4,6-Trihydroxy-3-hydroxymethyl-7-methoxy-11-methyl-5-oxo-1,2,3,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1.1: 72 percent / i-Pr2NEt / tetrahydrofuran; methanol / 2 h
2.1: 85 percent / Br2; (Bu3Sn)2O; MS-4A / CH2Cl2 / 0.25 h / -78 °C
3.1: 91 percent / Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
4.1: Zn / acetic acid / 0.03 h
5.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
5.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
6.1: NH2OH*HCl; TEA / methanol / 0.5 h
7.1: CDI / tetrahydrofuran / 0.75 h
8.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
9.1: 80 percent / formic acid / 1 h / 80 °C
10.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
11.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
12.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
C27H30BrNO8

C27H30BrNO8

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: Zn / acetic acid / 0.03 h
2.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
2.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
3.1: NH2OH*HCl; TEA / methanol / 0.5 h
4.1: CDI / tetrahydrofuran / 0.75 h
5.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
6.1: 80 percent / formic acid / 1 h / 80 °C
7.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
8.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
9.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
((1S,4aS,12aS)-3-Cyano-2,4a,6-trihydroxy-7-methoxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester
286961-74-8

((1S,4aS,12aS)-3-Cyano-2,4a,6-trihydroxy-7-methoxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid tert-butyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
2: 80 percent / formic acid / 1 h / 80 °C
3: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
4: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
5: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
[(1S,4aS,12aS)-2,4a,6-Trihydroxy-3-(hydroxyimino-methyl)-7-methoxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacen-1-yl]-carbamic acid tert-butyl ester

[(1S,4aS,12aS)-2,4a,6-Trihydroxy-3-(hydroxyimino-methyl)-7-methoxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydro-naphthacen-1-yl]-carbamic acid tert-butyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: CDI / tetrahydrofuran / 0.75 h
2: 68 percent / polyposphoric acid / 0.75 h / 100 °C
3: 80 percent / formic acid / 1 h / 80 °C
4: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
5: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
6: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
C27H32BrNO8
286961-70-4

C27H32BrNO8

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: 91 percent / Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
2.1: Zn / acetic acid / 0.03 h
3.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
3.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
4.1: NH2OH*HCl; TEA / methanol / 0.5 h
5.1: CDI / tetrahydrofuran / 0.75 h
6.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
7.1: 80 percent / formic acid / 1 h / 80 °C
8.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
9.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
10.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
((1S,2S,3S,12aR)-2,4,6-Trihydroxy-3-hydroxymethyl-7-methoxy-11-methyl-5-oxo-1,2,3,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid benzyl ester

((1S,2S,3S,12aR)-2,4,6-Trihydroxy-3-hydroxymethyl-7-methoxy-11-methyl-5-oxo-1,2,3,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid benzyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 13 steps
1.1: H2; TEA / Pd-black / dioxane; H2O / 1 h
2.1: 72 percent / i-Pr2NEt / tetrahydrofuran; methanol / 2 h
3.1: 85 percent / Br2; (Bu3Sn)2O; MS-4A / CH2Cl2 / 0.25 h / -78 °C
4.1: 91 percent / Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
5.1: Zn / acetic acid / 0.03 h
6.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
6.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
7.1: NH2OH*HCl; TEA / methanol / 0.5 h
8.1: CDI / tetrahydrofuran / 0.75 h
9.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
10.1: 80 percent / formic acid / 1 h / 80 °C
11.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
12.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
13.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
((1S,2S,3S,12aR)-2-Benzyloxy-3-benzyloxymethyl-4,6-dihydroxy-7-methoxy-11-methyl-5-oxo-1,2,3,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid benzyl ester
286961-68-0

((1S,2S,3S,12aR)-2-Benzyloxy-3-benzyloxymethyl-4,6-dihydroxy-7-methoxy-11-methyl-5-oxo-1,2,3,5,12,12a-hexahydro-naphthacen-1-yl)-carbamic acid benzyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 14 steps
1.1: BBr3 / CH2Cl2 / 0.25 h / -78 °C
2.1: H2; TEA / Pd-black / dioxane; H2O / 1 h
3.1: 72 percent / i-Pr2NEt / tetrahydrofuran; methanol / 2 h
4.1: 85 percent / Br2; (Bu3Sn)2O; MS-4A / CH2Cl2 / 0.25 h / -78 °C
5.1: 91 percent / Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
6.1: Zn / acetic acid / 0.03 h
7.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
7.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
8.1: NH2OH*HCl; TEA / methanol / 0.5 h
9.1: CDI / tetrahydrofuran / 0.75 h
10.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
11.1: 80 percent / formic acid / 1 h / 80 °C
12.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
13.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
14.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
((1S,2S,3S,12aR)-2-Benzyloxy-3-benzyloxymethyl-4,6,11-trihydroxy-7-methoxy-11-methyl-5-oxo-1,2,3,5,11,11a,12,12a-octahydro-naphthacen-1-yl)-carbamic acid benzyl ester
286961-67-9

((1S,2S,3S,12aR)-2-Benzyloxy-3-benzyloxymethyl-4,6,11-trihydroxy-7-methoxy-11-methyl-5-oxo-1,2,3,5,11,11a,12,12a-octahydro-naphthacen-1-yl)-carbamic acid benzyl ester

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
Multi-step reaction with 15 steps
1.1: 90 percent / SOCl2; TEA / CH2Cl2 / 0.17 h / -30 °C
2.1: BBr3 / CH2Cl2 / 0.25 h / -78 °C
3.1: H2; TEA / Pd-black / dioxane; H2O / 1 h
4.1: 72 percent / i-Pr2NEt / tetrahydrofuran; methanol / 2 h
5.1: 85 percent / Br2; (Bu3Sn)2O; MS-4A / CH2Cl2 / 0.25 h / -78 °C
6.1: 91 percent / Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
7.1: Zn / acetic acid / 0.03 h
8.1: Dess-Martin periodinane / acetonitrile; CH2Cl2 / 0.25 h
8.2: 60 percent / dimethyldioxirane; (R,R)-(PhCH-NTs)2BCl; TEA / CH2Cl2 / 0.5 h / -78 °C
9.1: NH2OH*HCl; TEA / methanol / 0.5 h
10.1: CDI / tetrahydrofuran / 0.75 h
11.1: 68 percent / polyposphoric acid / 0.75 h / 100 °C
12.1: 80 percent / formic acid / 1 h / 80 °C
13.1: 88 percent / BBr3 / CH2Cl2 / 15 h / 0 - 20 °C
14.1: 75 percent / O2; TPP / CHCl3 / 0.17 h / 20 - 40 °C / Irradiation
15.1: 62 percent / H2 / Pt-black / dioxane / 8 h / 2280 Torr
View Scheme
C36H32N2O9

C36H32N2O9

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
With hydrogen; palladium In 1,4-dioxane at 23℃; under 760.051 Torr; for 2.08333h;
omeprazole
73590-58-6

omeprazole

TETRACYCLINE
60-54-8

TETRACYCLINE

tetracycline hydrochloride
64-75-5

tetracycline hydrochloride

TETRACYCLINE
60-54-8

TETRACYCLINE

Conditions
ConditionsYield
In water pH=9; pH-value; Cooling;
formaldehyd
50-00-0

formaldehyd

TETRACYCLINE
60-54-8

TETRACYCLINE

1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid
70458-96-7

1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid

7-(4-{[(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonyl)-amino]-methyl}-piperazin-1-yl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

7-(4-{[(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonyl)-amino]-methyl}-piperazin-1-yl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

Conditions
ConditionsYield
In ethanol for 0.05h; Mannich reaction; microwave irradiation;78%
TETRACYCLINE
60-54-8

TETRACYCLINE

C20H17NO9

C20H17NO9

Conditions
ConditionsYield
With hydrogenchloride; N-chloro-succinimide In water at 25℃; for 0.5h;74.4%
formaldehyd
50-00-0

formaldehyd

TETRACYCLINE
60-54-8

TETRACYCLINE

1-cyclopropyl-7-(4-{[(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonyl)-amino]-methyl}-3-methyl-piperazin-1-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

1-cyclopropyl-7-(4-{[(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonyl)-amino]-methyl}-3-methyl-piperazin-1-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

Conditions
ConditionsYield
In ethanol for 0.05h; Mannich reaction; microwave irradiation;69%
formaldehyd
50-00-0

formaldehyd

TETRACYCLINE
60-54-8

TETRACYCLINE

ciprofloxacin
85721-33-1

ciprofloxacin

1-cyclopropyl-7-(4-{[(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonyl)-amino]-methyl}-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

1-cyclopropyl-7-(4-{[(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonyl)-amino]-methyl}-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

Conditions
ConditionsYield
In ethanol for 0.05h; Mannich reaction; microwave irradiation;61%
TETRACYCLINE
60-54-8

TETRACYCLINE

methyl iodide
74-88-4

methyl iodide

1,4,4a,5,5a,6,11,12a-octahydro-2-aminocarbonyl-3,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxonaphthacene-4-trimethylammonium iodide
6602-90-0

1,4,4a,5,5a,6,11,12a-octahydro-2-aminocarbonyl-3,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxonaphthacene-4-trimethylammonium iodide

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 96h;57%
In tetrahydrofuran at 20℃; for 144h;
formaldehyd
50-00-0

formaldehyd

TETRACYCLINE
60-54-8

TETRACYCLINE

lomefloxacin
98079-51-7

lomefloxacin

7-(4-{[(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonyl)-amino]-methyl}-3-methyl-piperazin-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

7-(4-{[(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonyl)-amino]-methyl}-3-methyl-piperazin-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

Conditions
ConditionsYield
In ethanol for 0.05h; Mannich reaction; microwave irradiation;54%
manganese(II) perchlorate hydrate

manganese(II) perchlorate hydrate

TETRACYCLINE
60-54-8

TETRACYCLINE

Mn(C22H24O8N2)2(OClO3)(1+)*ClO4(1-)=[Mn(C22H24O8N2)2(OClO3)]ClO4

Mn(C22H24O8N2)2(OClO3)(1+)*ClO4(1-)=[Mn(C22H24O8N2)2(OClO3)]ClO4

Conditions
ConditionsYield
In further solvent(s) the soln. of salt in ethanol/triethyl orthoformate was heated at 40-50°C, added tetracycline, refluxed for 24-48 h, concn. by heating under reduced prdssure, cooled to room temp.; filtered, washed with cold EtOH, dried in vac. over anhyd. CaCl2;42%
TETRACYCLINE
60-54-8

TETRACYCLINE

A

C20H17NO9

C20H17NO9

B

4-Oxo-4-dedimethylaminotetracyclin-hemiketal-(4.6)
3764-23-6

4-Oxo-4-dedimethylaminotetracyclin-hemiketal-(4.6)

Conditions
ConditionsYield
Stage #1: TETRACYCLINE With ethylenediaminetetraacetic acid; silver carbonate In N,N-dimethyl-formamide at 37℃; for 48h; Molecular sieve;
Stage #2: With dipotassium hydrogenphosphate; water; edetate disodium In N,N-dimethyl-formamide; acetonitrile at 0 - 20℃; for 8h; pH=5.5;
Stage #3: In chloroform at 0 - 5℃; for 168h;
A n/a
B 42%
formaldehyd
50-00-0

formaldehyd

TETRACYCLINE
60-54-8

TETRACYCLINE

4-nitrooxypiperidine
104963-85-1

4-nitrooxypiperidine

amido-N-[4-nitrooxypiperidinomethyl]-tetracycline

amido-N-[4-nitrooxypiperidinomethyl]-tetracycline

Conditions
ConditionsYield
In tetrahydrofuran for 4h; Inert atmosphere; Reflux;36%
In tetrahydrofuran for 4h; Reflux; Inert atmosphere;36%
formaldehyd
50-00-0

formaldehyd

TETRACYCLINE
60-54-8

TETRACYCLINE

4-amino-n-butyric acid
56-12-2

4-amino-n-butyric acid

C27H33N3O10

C27H33N3O10

Conditions
ConditionsYield
With acetic acid In ethanol at 20℃; for 12h; Mannich Aminomethylation;31%
TETRACYCLINE
60-54-8

TETRACYCLINE

A

2,5-dihydroxy-4-(((1S,4R,10S)-6-hydroxy-1-methyl-3,5-dioxo-1,3,4,5-tetrahydro-1,4-methanobenzo[c]oxepin-10-yl)methyl)-3,6-dioxocyclohexa-1,4-dienecarboxamide

2,5-dihydroxy-4-(((1S,4R,10S)-6-hydroxy-1-methyl-3,5-dioxo-1,3,4,5-tetrahydro-1,4-methanobenzo[c]oxepin-10-yl)methyl)-3,6-dioxocyclohexa-1,4-dienecarboxamide

B

2,3,5,6-tetrahydroxy-4-(((1S,4R,10S)-6-hydroxy-1-methyl-3,5-dioxo-1,3,4,5-tetrahydro-1,4-methanobenzo[c]oxepin-10-yl)methyl)benzamide

2,3,5,6-tetrahydroxy-4-(((1S,4R,10S)-6-hydroxy-1-methyl-3,5-dioxo-1,3,4,5-tetrahydro-1,4-methanobenzo[c]oxepin-10-yl)methyl)benzamide

Conditions
ConditionsYield
With mercury(II) diacetate; acetic acid at 50℃; for 48h;A 30%
B 10%
zinc(II) perchlorate hydrate

zinc(II) perchlorate hydrate

TETRACYCLINE
60-54-8

TETRACYCLINE

Zn(C22H24O8N2)2(OClO3)(1+)*ClO4(1-)=[Zn(C22H24O8N2)2(OClO3)]ClO4

Zn(C22H24O8N2)2(OClO3)(1+)*ClO4(1-)=[Zn(C22H24O8N2)2(OClO3)]ClO4

Conditions
ConditionsYield
In further solvent(s) the soln. of salt in ethanol/triethyl orthoformate was heated 40-50°C, added tetracycline, refluxed for 24-48 h, concn. by heating underreduced pressure, cooled to room temp.; filtered, washed with cold EtOH, dried in vac. over anhyd. CaCl2;28%
TETRACYCLINE
60-54-8

TETRACYCLINE

C22H24N2O9

C22H24N2O9

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In methanol for 0.0833333h; Solvent; Inert atmosphere; Cooling with ice;27%
TETRACYCLINE
60-54-8

TETRACYCLINE

2,5-dihydroxy-4-(((1S,4R,10S)-6-hydroxy-1-methyl-3,5-dioxo-1,3,4,5-tetrahydro-1,4-methanobenzo[c]oxepin-10-yl)methyl)-3,6-dioxocyclohexa-1,4-dienecarboxamide

2,5-dihydroxy-4-(((1S,4R,10S)-6-hydroxy-1-methyl-3,5-dioxo-1,3,4,5-tetrahydro-1,4-methanobenzo[c]oxepin-10-yl)methyl)-3,6-dioxocyclohexa-1,4-dienecarboxamide

Conditions
ConditionsYield
In dimethyl sulfoxide at 30℃; for 48h;26%
formaldehyd
50-00-0

formaldehyd

TETRACYCLINE
60-54-8

TETRACYCLINE

glycine
56-40-6

glycine

C25H29N3O10

C25H29N3O10

Conditions
ConditionsYield
With acetic acid In ethanol at 20℃; for 12h; Mannich Aminomethylation;24%
morpholine
110-91-8

morpholine

TETRACYCLINE
60-54-8

TETRACYCLINE

Glyoxilic acid
298-12-4

Glyoxilic acid

(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonylamino)-morpholin-4-yl-acetic acid
13729-37-8

(4-dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carbonylamino)-morpholin-4-yl-acetic acid

Conditions
ConditionsYield
In tert-butyl alcohol Heating;
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

TETRACYCLINE
60-54-8

TETRACYCLINE

C31H48N2O8Si3

C31H48N2O8Si3

Conditions
ConditionsYield
With 1,1,1,3,3,3-hexamethyl-disilazane In pyridine at 20℃; for 0.0166667h;
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

TETRACYCLINE
60-54-8

TETRACYCLINE

C37H64N2O8Si5

C37H64N2O8Si5

Conditions
ConditionsYield
With 1,1,1,3,3,3-hexamethyl-disilazane In pyridine at 20℃; for 12h;
TETRACYCLINE
60-54-8

TETRACYCLINE

1-Cyclohex-1-enyl-piperidine; compound with perchloric acid

1-Cyclohex-1-enyl-piperidine; compound with perchloric acid

(4S,4aS,5aS,6S,12aS)-4-Dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid cyclohex-1-enylamide

(4S,4aS,5aS,6S,12aS)-4-Dimethylamino-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid cyclohex-1-enylamide

Conditions
ConditionsYield
(i) DMF, (ii) piperidine; Multistep reaction;
2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

TETRACYCLINE
60-54-8

TETRACYCLINE

guanine*tetracycline
78696-74-9

guanine*tetracycline

Conditions
ConditionsYield
In water at 23℃; formation constant; further solvents;;
L-phenylalanine
63-91-2

L-phenylalanine

TETRACYCLINE
60-54-8

TETRACYCLINE

phenylalanine*tetracycline
78696-79-4

phenylalanine*tetracycline

Conditions
ConditionsYield
In water at 23℃; formation constant; further solvents;;
TETRACYCLINE
60-54-8

TETRACYCLINE

4-epi-anhydrotetracycline
1665-57-2

4-epi-anhydrotetracycline

Conditions
ConditionsYield
With 2-hydroxyethanethiol at 4℃; Irradiation; Title compound not separated from byproducts;
TETRACYCLINE
60-54-8

TETRACYCLINE

L-tyrosine
60-18-4

L-tyrosine

tyrosine*tetracycline
78696-80-7

tyrosine*tetracycline

Conditions
ConditionsYield
In water at 23℃; formation constant; further solvents;;
TETRACYCLINE
60-54-8

TETRACYCLINE

uracil
66-22-8

uracil

uracil*tetracycline
78696-78-3

uracil*tetracycline

Conditions
ConditionsYield
In water at 23℃; formation constant; further solvents;;
TETRACYCLINE
60-54-8

TETRACYCLINE

thymin
65-71-4

thymin

thymine*tetracycline
78696-77-2

thymine*tetracycline

Conditions
ConditionsYield
In water at 23℃; formation constant; further solvents;;
TETRACYCLINE
60-54-8

TETRACYCLINE

hypoxanthine
68-94-0

hypoxanthine

hypoxanthine*tetracycline
78696-76-1

hypoxanthine*tetracycline

Conditions
ConditionsYield
In water at 23℃; formation constant; further solvents;;
Conditions
ConditionsYield
In water at 23℃; formation constant; further solvents;;
TETRACYCLINE
60-54-8

TETRACYCLINE

xanthine
69-89-6

xanthine

xanthine*tetracycline
78696-75-0

xanthine*tetracycline

Conditions
ConditionsYield
In water at 23℃; formation constant; further solvents;;

Tetracycline History

The Tetracycline (CAS NO.60-54-8) are a large family of antibiotics that were discovered as natural products by Benjamin Minge Duggar and first described in 1948. Tetracycline was then discovered by Lloyd Conover in the research departments of Pfizer. The patent for tetracycline, U.S. Patent 2,699,054, was first issued in 1950. However, Nubian mummies have been studied in the 1990s and were found to contain significant levels of tetracycline; there is evidence that the beer brewed at the time could have been the source. Tetracycline sparked the development of many chemically altered antibiotics and in doing so has proved to be one of the most important discoveries made in the field of antibiotics.

Tetracycline Consensus Reports

EPA Genetic Toxicology Program.

Tetracycline Specification

The Tetracycline with CAS registry number of 60-54-8 is also known as Abramycin. The IUPAC name is (2Z,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione. It belongs to product categories of Antibiotic Explorer; Intermediates & Fine Chemicals; Pharmaceuticals; Antibacterial; Antibiotics; Antibiotics A to; Antibiotics by Application; Antibiotics T-ZAntibiotics; Chemical Structure Class; Genetic Marker SelectionAntibiotics; Interferes with Protein SynthesisSpectrum of Activity; L-ZAntibiotics; Mechanism of Action; Tetracyclines; Peptide Synthesis/Antibiotics. Its EINECS registry number is 200-481-9. In addition, the formula is C22H24N2O8 and the molecular weight is 444.43. This chemical is a light yellow crystal and should be sealed in dry, dark place under 0 °C.

Physical properties about Tetracycline are: (1)ACD/LogP: 0.62; (2)# of Rule of 5 Violations: 2 ; (3)ACD/BCF (pH 5.5): 1; (4)ACD/BCF (pH 7.4): 1; (5)ACD/KOC (pH 5.5): 1; (6)ACD/KOC (pH 7.4): 1; (7)#H bond acceptors: 10; (8)#H bond donors: 7; (9)#Freely Rotating Bonds: 7; (10)Index of Refraction: 1.741; (11)Molar Refractivity: 109.088 cm3; (12)Molar Volume: 270.304 cm3; (13)Surface Tension: 100.608 dyne/cm; (14)Density: 1.644 g/cm3; (15)Flash Point: 431.953 °C; (16)Enthalpy of Vaporization: 120.61 kJ/mol; (17)Boiling Point: 790.622 °C at 760 mmHg.

Preparation of Tetracycline: it is prepared by reaction of 6-deoxy-6-hydroperoxy-5a,11a-dehydrotetracycline. The reaction needs reagent H2, catalyst Pt-black and solvent dioxane at the pressure of 2280 for 8 hours. The yield is about 62%.

Tetracycline is prepared by reaction of 6-deoxy-6-hydroperoxy-5a,11a-dehydrotetracycline.

Uses of Tetracycline: it is first-line therapy for Rocky Mountain spotted fever, Q fever, psittacosis and lymphogranuloma venereum, and to eradicate nasal carriage of meningococci. What's more, it is used as a marker of bone growth for biopsies in humans. It is also used as a biomarker in wildlife and in transcriptional activation.

When you are using this chemical, please be cautious about it. As a chemical, it is irritating to eyes, respiratory system and skin. And it is harmful if swallowed. During using it, wear suitable protective clothing. Do not breathe dust. If contact with eyes accidently, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
1. Canonical SMILES: CC1(C2CC3C(C(=O)C(=C(N)O)C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O
2. Isomeric SMILES: C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)/C(=C(\N)/O)/C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O
3. InChI: InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25-26,30-32H,7,23H2,1-3H3/b20-14-/t9-,10-,15-,21+,22-/m0/s1
4. InChIKey: JYHCQVWYCGHXGP-BPPSBWQWSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
guinea pig LD50 oral 1875mg/kg (1875mg/kg)   "Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982Vol. -, Pg. 109, 1982.
mouse LD50 intraperitoneal 120mg/kg (120mg/kg)   "Index of Antibiotics from Actinomycetes," Umezawa, H. et al., eds., Tokyo, Univ. of Tokyo Press, 1967Vol. -, Pg. 134, 1967.
mouse LD50 intravenous 157mg/kg (157mg/kg)   Farmaco, Edizione Scientifica. Vol. 10, Pg. 346, 1955.
mouse LD50 oral 678mg/kg (678mg/kg)   American Journal of Tropical Medicine and Hygiene. Vol. 2, Pg. 254, 1953.
mouse LD50 subcutaneous 400mg/kg (400mg/kg)   "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 3, Pg. 42, 1980.
rat LD50 intraperitoneal 310mg/kg (310mg/kg)   Drugs in Japan Vol. 6, Pg. 493, 1982.
rat LD50 intravenous 129mg/kg (129mg/kg)   Antibiotics and Chemotherapy Vol. 4, Pg. 411, 1954.
rat LD50 oral 807mg/kg (807mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
women LDLo multiple routes 310mg/kg (310mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED"
New England Journal of Medicine. Vol. 270, Pg. 157, 1964.
women TDLo oral 600mg/kg/15D (600mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: DECREASED MOTILITY OR CONSTIPATION

KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED
Southern Medical Journal. Vol. 71, Pg. 961, 1978.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View